1) Hayhurst MD, MacNee W, Flenley DC, et al. Diagnosis of pulmonary emphysema by computerised tomography. Lancet. 1984; 2: 320-2
|
|
|
2) Bergin CJ, Müller NL, Miller RR. CT in the qualitative assessment of emphysema. J Thorac Imaging. 1986; 1: 94-103
|
|
|
3) Müller NL, Staples CA, Miller RR, et al. “Density mask". An objective method to quantitate emphysema using computed tomography. Chest. 1988; 94: 782-7
|
|
|
4) McNamara AE, Müller NL, Okazawa M, et al. Airway narrowing in excised canine lungs measured by high-resolution computed tomography. J Appl Physiol. 1992; 73: 307-16
|
|
|
5) Wood SA, Zerhouni EA, Hoford JD, et al. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol. 1995; 79: 1687-97
|
|
|
6) Okazawa M, Müller N, McNamara AE, et al. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit Care Med. 1996; 154: 1557-62
|
|
|
7) Reinhardt JM, D'Souza ND, Hoffman EA. Accurate measurement of intrathoracic airways. IEEE Transactions on Medical Imaging. 1997; 16: 820-7
|
|
|
8) King GG, Müller NL, Whittall KP, et al. An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data. Am J Respir Crit Care Med. 2000; 161(2 Pt 1): 574-80
|
|
|
9) Awadh N, Müller NL, Park CS, et al. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax. 1998; 53: 248-53
|
|
|
10) Niimi A, Matsumoto H, Amitani R, et al. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med. 2000; 162(4 Pt 1): 1518-23
|
|
|
11) Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med. 2000; 162: 1102-8
|
|
|
12) Mishima M, Oku Y, Kawakami K, et al. Quantitative assessment of the spatial distribution of low attenuation areas on X-ray CT using texture analysis in patients with chronic pulmonary emphysema. Front Med Biol Eng. 1997; 8: 19-34
|
|
|
13) Mishima M, Hirai T, Itoh H, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A. 1999; 96: 8829-34
|
|
|
14) Mitsunobu F, Ashida K, Hosaki Y, et al. Complexity of terminal airspace geometry assessed by computed tomography in asthma. Am J Respir Crit Care Med. 2003; 167: 411-7
|
|
|
15) Park KJ, Bergin CJ, Clausen JL. Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology. 1999; 211: 541-7
|
|
|
16) Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173: 1309-15
|
|
|
17) Arakawa A, Yamashita Y, Nakayama Y, et al. Assessment of lung volumes in pulmonary emphysema using multidetector helical CT: comparison with pulmonary function tests. Comput Med Imaging Graph. 2001; 25: 399-404
|
|
|
18) Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968; 278: 1355-60
|
|
|
19) Annotator. Blue bloater: pink puffer. Br Med J. 1968; 2: 677
|
|
|
20) Rennard SI. Looking at the patient-approaching the problem of COPD. N Engl J Med. 2004; 350: 965-6
|
|
|
21) Nakano Y, Müller NL, King GG, et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest. 2002; 122(6 Suppl): 271S-5S
|
|
|
22) Ogawa E, Nakano Y, Ohara T, et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax. 2009; 64: 20-5
|
|
|
23) Hasegawa M, Makita H, Nasuhara Y, et al. Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD. Thorax. 2009; 64: 332-8
|
|
|
24) Lee JH, Lee YK, Kim EK, et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med. 2010; 104: 542-9
|
|
|
25) ECLIPSE. [cited 2010/09/12. ]; Available from: http://www.eclipse-copd.com/home.aspx
|
|
|